View Cellectar Biosciences, Inc. CLRB investment & stock information. Get the latest Cellectar Biosciences, Inc. CLRB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Cellectar Biosciences - Stock Split History | CLRB ... Stock split history for Cellectar Biosciences since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Cellectar says tumors shrank as much as 90 percent in ... Aug 12, 2018 · Cellectar Biosciences, a Madison company working on cancer-fighting medications, is cheering early patient test results of its main compound, but it has ended production of the drug here, cutting jobs, and last week the company learned its supply of the drug has been temporarily halted by federal regulators. Cellectar Biosciences issues reserve stock split | Madison ... Jul 14, 2018 · Cellectar Biosciences, a publicly-traded Madison biopharmaceutical company working on cancer treatments, enacted a 10-for-1 reverse stock split on Friday, effective at the close of business for the day. That means for every 10 shares of Cellectar's common stock, holders will own 1 share, reducing the number of outstanding common shares from 18
How did Cellectar Biosciences' stock split work? Cellectar Biosciences shares reverse split on the morning of Tuesday, July 17th 2018. The 1-10 reverse split was
CLRB - Cellectar Biosc Stock Profile - Barchart.com Company profile for Cellectar Biosc (CLRB) including business summary, key statistics, ratios, sector. Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. Most Recent Split: The share split recorded and the date on which the split occurred. Cellectar Biosciences, Inc. (Form: 8-K, Received: 03/04 ... MADISON, WI (March 4, 2016) – Cellectar Biosciences, Inc. (NASDAQ: CLRB), an oncology-focused biotechnology company, today announces a 1-for-10 reverse stock split of its common stock, effective at the close of business today. Shares of Cellectar’s common stock will trade on a post-split basis beginning on March 7, 2016. Cellectar Biosciences Announces 1-for-20 Reverse Stock ... Jun 13, 2014 · Cellectar Biosciences Announces 1-for-20 Reverse Stock Split and Reduction in Authorized Shares of Common Stock MADISON, Wis., June 13, 2014 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (OTCQX:CLRB), announced a 1-for-20 reverse stock split of its common stock, effective at the close of business today, as a first step in a planned CLRB - Research and Analysis for CELLECTAR BIOSCIENCES ...
Cellectar Biosciences Inc. company facts, information and stock details by MarketWatch. View clrb business summary and other industry information.
Cellectar Biosciences, Inc. Common Stock (CLRB) Financials Find the latest Financials data for Cellectar Biosciences, Inc. Common Stock (CLRB) at Nasdaq.com.